Salbutamol
Novolizer Salbutamol Meda, Salbutamol Glenmark, Salbutamol Noridem, Salbutamol Sandoz · ATC code R03CC02
Also known as: Salbutamolo, Albuterol Sulfate · Brand names: Apsomol N Für Erwachsene Und Kinder Ab, Bronchospray Autohaler, Bronchospray Novo, Cyclocaps, Fertiginhalat, Inhalat, Novolizer, Salbu Easyhaler, Salbubronch Elixier, Salbubronch Forte, Salbuhexal Dosieraerosol, Salbuhexal N Dosieraerosol, Salbuhexal N Hexal Ag, Salbulair N, Sultanol Dosier-Aerosol …
- Key facts
- Active substance
- Salbutamol
- ATC code
- R03CC02
- Authorisation
- authorised nationally; no central EU authorisation
- Information as of
- 2026-11-03
Key facts
Salbutamol (US name albuterol) is a short-acting beta-adrenergic agonist bronchodilator. Per the US label the metered-dose inhalation aerosol is used to treat or prevent bronchospasm and to prevent exercise-induced bronchospasm in patients 4 years of age and older.
What it is used for
- Treatment or prevention of bronchospasm in reversible obstructive airway disease, patients 4 years of age and older
- Prevention of exercise-induced bronchospasm, patients 4 years of age and older
Dosing
- Adults and children 4 years and older: two inhalations every 4 to 6 hours; in some patients one inhalation every 4 hours may be sufficient
- More frequent administration or a larger number of inhalations is not recommended
- Exercise-induced bronchospasm: two inhalations 15 to 30 minutes before exercise
- Each actuation delivers 90 mcg of albuterol base from the mouthpiece; shake well before each spray
- Prime with three sprays before first use or if unused for more than 2 weeks; clean the mouthpiece at least once a week
Contraindications
- History of hypersensitivity to albuterol or any other component of the product
Important warnings
- Paradoxical bronchospasm, possibly life threatening and often with the first use of a new canister; discontinue immediately
- Needing more doses than usual signals deteriorating asthma; reassess treatment, including the need for anti-inflammatory therapy such as corticosteroids
- Cardiovascular effects (pulse, blood pressure, ECG changes such as QTc prolongation); caution in coronary insufficiency, arrhythmias and hypertension
- Fatalities reported with excessive use of inhaled sympathomimetics; do not exceed the recommended dose
- Immediate hypersensitivity reactions (urticaria, angioedema, rash, anaphylaxis); significant, usually transient hypokalemia
- Caution in convulsive disorders, hyperthyroidism and diabetes mellitus
Side effects
- In the adult trial: pharyngitis, headache, rhinitis, tachycardia, pain, dizziness
- Tremor, nervousness and headache most frequent in cumulative-dose studies
- Postmarketing: palpitations, arrhythmias (including atrial fibrillation), hypertension or hypotension, insomnia, muscle cramps, throat irritation, hypokalemia, hyperglycemia
Interactions
- Other short-acting sympathomimetic aerosol bronchodilators: do not use concomitantly; other adrenergic drugs with caution
- Beta-blockers block the effect and may cause severe bronchospasm in asthma; if unavoidable, consider cardioselective agents with caution
- Non-potassium sparing diuretics (loop, thiazide): ECG changes and hypokalemia may worsen; consider monitoring potassium
- Digoxin: serum digoxin levels may fall; evaluate levels
- MAO inhibitors or tricyclic antidepressants, or within 2 weeks of stopping them: extreme caution because cardiovascular effects may be potentiated
Pregnancy and breastfeeding
- Available human data do not consistently show a risk of major birth defects or miscarriage; poorly controlled asthma itself raises maternal and neonatal risks
- During labor, use only when benefits clearly outweigh the risk (possible interference with uterine contractility); not approved for pre-term labor
- No data on albuterol in human milk; plasma levels after inhalation are low
Summary of the official product information, written with AI on 2026-11-03. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Patient information (US)
This product has no separate US patient information.
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
Germany
- Apsomol N Für Erwachsene Und Kinder AbJensonr+ (Ireland) Ltd · 1 register entry
- Bronchospray AutohalerJensonr+ (Ireland) Ltd · 1 register entry
- Bronchospray NovoJensonr+ (Ireland) Ltd · 1 register entry
- CyclocapsPb Pharma Gmbh · 1 register entry
- FertiginhalatStadapharm Gmbh · 2 register entries
- InhalatStadapharm Gmbh · 1 register entry
- NovolizerViatris Healthcare Gmbh · 1 register entry
- Salbu EasyhalerOrion Corporation · 1 register entry
- Salbubronch ElixierInfectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim · 1 register entry
- Salbubronch ForteInfectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim · 1 register entry
- Salbuhexal DosieraerosolHexal Ag · 1 register entry
- Salbuhexal N DosieraerosolHexal Ag · 1 register entry
Show all 20 brand names
- Salbuhexal N Hexal AgHexal Ag · 1 register entry
- Salbulair NTeva Gmbh · 1 register entry
- Salbutamol1 A Pharma Gmbh, Ratiopharm Gmbh, Aliud Pharma Gmbh, Glenmark Arzneimittel Gmbh, Noridem Enterprises Ltd, Neutec Inhaler Ireland Ltd, Teva Gmbh · 10 register entries
- Sultanol Dosier-AerosolGlaxosmithkline Gmbh & Co. Kg · 1 register entry
- Sultanol FertiginhalatGlaxosmithkline Gmbh & Co. Kg · 1 register entry
- Sultanol Forte FertiginhalatGlaxosmithkline Gmbh & Co. Kg · 1 register entry
- Sultanol InhalationslösungGlaxosmithkline Gmbh & Co. Kg · 1 register entry
- Ventilastin NovolizerViatris Healthcare Gmbh · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-11-03
Austria
- Novolizer Salbutamol MedaViatris Healthcare Limited · 1 register entry
- Salbutamol GlenmarkGlenmark Arzneimittel Gmbh · 1 register entry
- Salbutamol NoridemNoridem Enterprises Ltd · 1 register entry
- Salbutamol SandozSandoz Gmbh · 1 register entry
- SultanolGlaxosmithkline Pharma Gmbh. · 3 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-11-03
Turkey
- BerastBERKO İLAÇ VE KİMYA SAN. A.Ş. · 2 register entries
- BronkasNOBEL İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- MetrastSANOVEL İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- Salbutam SRNOBEL İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
- Salodil SRULKAR KİMYA SAN. VE TİC. A.Ş. · 4 register entries
- SalresDEVA HOLDİNG A.Ş. · 1 register entry
- VentolinGLAXOSMİTHKLİNE İLAÇLARI SAN. VE TİC. A.Ş. · 1 register entry
- VentosalBİLİM İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- VentubolLİLYUM İLAÇ VE KİMYA SAN. TİC. LTD. ŞTİ. · 5 register entries
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-11-03
Brand names in 27 more European countries
- Belgium
- Airomir, Novolizer Salbutamol, Salbutamol Neutec, Salbutamol Noridem, Salbutamol Novolizer Meda Pharma, Ventolin
- Bulgaria
- Buto-Asma, Вентолин, Екосал Инхалер, Салбутамол Wzf, Салбутамол Софарма
- Croatia
- Antamenys, Salbutamol Pliva
- Cyprus
- Brodilaten Noridem Enterprises, Medolin, Ventolin
- Czechia
- Buventol Easyhaler, Ecosal Inhaler, Salbutamol Noridem, Salbutamol Polpharma, Ventolin
- Denmark
- Airomir, Airsalb, Buventol Easyhaler, Salamol, Salbutamol "neutec", Salbutamol Noridem, Salbutamol Teva, Ventoline
- Estonia
- Buventol Easyhaler, Ventolin
- Finland
- Airomir, Buventol Easyhaler, Salbutamol Neutec, Ventilastin Novolizer, Ventoline
- France
- Airomir Autohaler, Salbumol, Salbutamol, Ventilastin Novolizer, Ventoline
- Greece
- Aerolin, Asthmotrat, Brodilaten
- Hungary
- Buventol Easyhaler, Ventolin Evohaler
- Iceland
- Salbutamol Neutec, Ventoline
- Ireland
- Brodilaten, Salamol, Salbutamol Neutec, Ventolin
- Italy
- Broncovaleas, Salbutamol Noridem, Salbutamolo Glenmark, Salbutamolo Noridem, Salbutamolo Sandoz, Ventolin
- Latvia
- Salbutamol Inteli, Ventolin
- Lithuania
- Salbutamol Inteli, Ventolin
- Luxembourg
- Airomir, Novolizer Salbutamol, Ventolin
- Malta
- Ventoaldo, Ventolin
- Netherlands
- Airomir Autohaler, Airomir Inhalator, Salamol Steri-Neb, Salbutamol, Ventolin
- Norway
- Airomir, Buventol Easyhaler, Salbutamol Neutec, Ventoline
- Poland
- Aspulmo, Buventol Easyhaler, Lerhasa, Salbutamol Hasco, Salbutamol Wzf, Ventolin
- Portugal
- Salbutamol Gp, Salbutamol Noridem, Salbutamol Novolizer, Salbutamol Sandoz, Ventilan
- Romania
- Salbutamol, Ventolin
- Slovakia
- Salbutamol Noridem, Ventolin
- Slovenia
- Antamenys, Ventolin
- Spain
- Aldobronquial, Salbuair, Salbutamol Aldo-Unión, Salbutamol Glenmark, Salbutamol Neutec, Salbutamol Sandoz, Ventoaldo, Ventolin
- Sweden
- Airomir, Airsalb, Buventol Easyhaler, Salbutamol, Ventilastin Novolizer, Ventoline
EMA – Article 57 product data (EU/EEA), 2026-11-03
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- U.S. Food and Drug Administration. Albuterol Sulfate (Armstrong Pharmaceuticals, Inc.) – Prescribing Information, 2026-08-06. DailyMed (NLM), 2026-11-03. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17858afa-dcdf-4612-b475-3b6baadfb639
- EMA – Article 57 product data (EU/EEA), 2026-11-03. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-11-03. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-11-03. https://www.titck.gov.tr/dinamikmodul/85
Editorial: Medelix editorial team · last updated 2026-11-03 · How these pages are made · Report an error
Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.